FARA Flash Talks 2026 — Session 1

Session 1: Understanding and treating nerve damage in Friedreich’s Ataxia Agostina Di Pizio (Ospedale San Raffaele) Studying a rare frataxin mutation in zebrafish to find new clues about Friedreich's ataxia Jessy van Asperen (Institute Neuromyogène, University of Lyon) Analyzing Friedreich's ataxia hearts at single cell level Vi Tang (Harvard University) Session 1 was moderated by FA community members Gabrielle Angiolelli and Anna Morrow. ___________________ FARA's Mission is to marshal and focus the resources and relationships needed to cure Friedreich's Ataxia (FA) by raising funds for research, promoting public awareness, and aligning scientists, patients, clinicians, government agencies, pharmaceutical companies and other organizations dedicated to curing FA and related diseases. Friedreich’s Ataxia is a debilitating, life-shortening, degenerative neuro-muscular disorder. About one in 50,000 people in the United States have Friedreich's Ataxia. Subscribe to FARA's YouTube channel    / fara1998   Follow FARA on Facebook   / curefa   Follow FARA on Instagram   / curefa_org